Cotinine Screening Devices Market Emerging Trends by 2028 | Germaine Laboratories, Inc.

Global Cotinine Screening Devices Market: Overview

The cotinine screening devices market has progressed rapidly, catalyzed by technologies that enable rapid as well reliable detection of smoking status in patients. Uptake of these technologies hinges on evaluating how well these meet the requirements of convenience, reliability, and cost. A case in point is the popularity of oral fluid testing devices that measure cotinine level in saliva, urine, and blood. Growing application of such devices to aid nicotine cessation therapies in corrective and workplace settings is also boosting the market. Of note, cotinine is a major nicotine metabolite. The use of non-invasive markers has expanded the potential of the cotinine screening devices market considerably.

Get Sample Copy of the Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6076

Advances in laboratory instrumentation and reagents have been key enablers or accelerators for the growth of the cotinine screening devices market. However, there is still dearth of technology that can delineate active smoking from passive exposure in individuals, posing considerable challenge to medical companies in the cotinine screening devices market. The various types of products in the cotinine screening devices market comprise cassettes, strips, and readers.

Global Cotinine Screening Devices Market: Key Drivers

Mounting concern of tobacco dependence has augmented the risks of wide range of oral diseases and adverse oral conditions in worldwide populations. This is one of the key drivers of cotinine screening devices market. Advancements in quantitative methods to measure urine cotinine level is a key trend boosting the market. Notable developments have been in the advent of high- performance liquid chromatography.

Request TOC of the Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=6076

On the other hand, increasing incidence of passive smoking or secondhand smoke (SHS)-related disease in adolescents is also a compelling concern. This has spurred the demand for biochemical assessment of tobacco smoke exposure in cotinine screening devices market. The need for better interventions that use routine biochemical screening has bolstered the use of cotinine screening devices in this regard. In many cases, such interventions are gathering traction in reducing exposure in children. This is particularly important given the high risk of risk of smoking initiation in children.

A robust momentum in the cotinine screening devices market has come from the rapidly increasing trend of e-cigarettes among youth populations. The intake of nicotine via e-cigarettes has further gathered a marked heat in various parts of the world, mainly from the growing use of electronic nicotine delivery systems and electronic non-nicotine delivery systems (ENDS/ENNDS).

Healthcare providers are increasingly adopting advanced diagnostics for cotinine in tobacco users. This is also cementing the potential of the cotinine screening devices market.

Global Cotinine Screening Devices Market: Notable Developments

Over the past few years, point-of-care tobacco detection has made considerable strides especially in developed countries. This has created new avenues in the cotinine screening devices market. In the U.S. such point-of-care portable devices are gathering steam in hospital chains. A case in point is the sizable adoption of PTS Detect cotinine system for point-of-care tobacco-detection in numerous hospitals. The system launched in 2015 was one-of-its kind cotinine screening device that offered definitive results just by a fingerstick. The non-invasiveness of the technique might have been a key factor for the growing popularity over the years since the launch.

Numerous research has taken place which expanded their applications in new clinical areas. One such application of point-of-care cotinine screening device in prenatal care. This is gathering steam in the health care industry, since a growing numbers of expectant mothers underreport exposure to tobacco.

Some of the well-entrenched players in the cotinine screening devices market are Germaine Laboratories, Inc., Hangzhou Clongene Biotech Co., Ameritek USA., ALFA Scientific, LifeSign LLC, Nano-Ditech Corp, and Mossman Associates.

Global Cotinine Screening Devices Market: Regional Assessment

Some of the key regions in the cotinine screening devices market are the Middle East and Africa, Europe, Latin America, North America, and Asia Pacific. Of these, North America has shown vast potential and has been presenting substantial lucrative opportunities for medical device makers to capitalize on. The regional market has prospered on the back of the adoption of comprehensive health insurance plans in the U.S. and robust initiatives taken by the healthcare industries to reduce or prevent tobacco exposure.

About TMR Research:

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050

This release was published on openPR.